Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Partikula

Partikula
2013 FOUNDED
OOB STATUS
Out of Business LATEST DEAL TYPE
Description

Developer of novel therapeutics designed to treat oncology and other diseases. The company's therapeutics utilize proprietary chemical engineering technologies to develop compounds that specifically and directly target mitochondria, from the outer mitochondrial membrane to the mitochondrial matrix and areas in between, enabling patients to fight off a large number of major diseases including cancer, neurodegenerative disease, cardiovascular and metabolic disease and a number of rare orphan diseases.

Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Primary Industry
Biotechnology
Other Industries
Pharmaceuticals
Drug Discovery
Primary Office
  • 15491 South West 12th Street
  • Suite 408
  • Sunrise, FL 33326
  • United States

+1 (954) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Partikula’s full profile, request a free trial.

Partikula Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Out of Business 01-Apr-2018 00.000 Completed Out of Business
4. Debt - General 30-Jun-2016 00.000 Completed Startup
3. Debt - General 20-Nov-2015 00.000 Completed Startup
2. Early Stage VC (Series A) 02-Feb-2015 $5M $5.15M Completed Startup
1. Angel (individual) 25-Mar-2014 $150K $150K Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Partikula Competitors (21)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Khondrion Corporation Nijmegen, Netherlands 00 0000000000
00000 Venture Capital-Backed Pittsburgh, PA 00 000.00 0000000000 0 000.00
000000000 00000000 Venture Capital-Backed 000.00 0000000000 0 000.00
00 000000000000 Formerly VC-backed Durham, NC 00 00000 000000 - 000 00000
000000 Venture Capital-Backed Cambridge, United Kingdom 00 0000 000000 - 000 0000
To view this company’s complete list of competitors, request access »

Partikula Executive Team (4)

Name Title Board
Seat
Contact
Info
Shanta Dhar Ph.D Scientific Founder
Nagesh Kolishetti Ph.D Vice President of Chemistry and Chemical Development
Marc Lippman MD Chief Medical Officer
David Kolb Chief Executive Officer, Co-Founder & Board Member

Partikula Board Members (4)

Name Representing Role Since Contact
Info
David Kolb Self Chief Executive Officer, Co-Founder & Board Member 000 0000

3 Former Board Members

You’re viewing 1 of 4 board members. Get the full list »